--NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT TO BIOVERIS CORPORATION TO PROVIDE ANTHAX SPORE TEST KITS TO OPERATE THE M8 ASSAY DEVELOPMENT WORKSTATION AND PERFORM REQUIRED ANALYSIS.

BioVeris Corporation develops and markets biological detection systems based on its proprietary electrochemiluminescent echnology (BioVeris tm(BVtm) detection technology), which provies a unique combination of sensitivity, reliability, speed, and fle xibility. BioVeris incorporates its BVtm detection technology into its instrument systems, tests, and reagents, which are the biological and chemical components used to perform such tests. BiVeris Corporations's worldwide patent portfolio bradly covers t he use of BV technology in diagnostic and other biological applications. this notice of intent is not a request for competitive proposals or a solicitation of offers. The point of contact for this action is Irene Mancuso, Contract specialist, 410-278-1941, [email protected].